JHVEPhoto
- OptumRx, the pharmacy benefit manager owned by UnitedHealth Group (NYSE:UNH), will pay $20M as part of a settlement with the Department of Justice over improperly filing some opioid prescriptions.
- A DEA investigation found that between April 2013 and April 2015, OptumRx filled opioid prescription orders along with scripts for benzodiazepines and muscle relaxants, a combination known as "trinity" prescriptions because of likelihood of abuse.
- The agency noted that most of the prescriptions came from the same mail-order pharmacy and raised red flags. However, the DEA alleges that many of those orders were filled without resolving the red flags.
More on UnitedHealth
- UnitedHealth Group: Uncertainties Through 2025 Reiterate Buy Opportunity
- I'm Sticking To My Call: UnitedHealth Is Among The Best Dividend Growers
- UnitedHealth Group: Don't Miss Out On This Dividend Growth Beast
- UnitedHealth and Cigna PBMs face Arkansas lawsuit over role in opioid crisis
- UnitedHealth contacting customers impacted by cyberattack in July